Tvardi Therapeutics Tvardi Therapeutics is a biotechnology company developing medicines for the treatment of cancer, chronic inflammation, and fibrosis. | Eleison Pharmaceuticals Eleison Pharmaceuticals is a company engaged in the discovery and commercialization of drug candidates for cancers. | ![]() NiKang Therapeutics NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines. | ![]() HDT Bio HDT Bio is a biopharmaceutical company intended to develop biotherapeutics for oncology and infectious disease applications. | Elevation Oncology Elevation Oncology is a biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers. | |
Founding Date | Founding Date 2017 | Founding Date 2008 | Founding Date 2017 | Founding Date 2018 | Founding Date 2019 |
Type | Type Private | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Houston, US HQ Houston, US | Locations Princeton, US HQ | Locations Wilmington, US HQ | Locations Seattle, US HQ | Locations New York, US HQ |
Employees | Employees 19 | Employees 12 | Employees 403% increase | Employees 63 | Employees 8 |
Funding | |||||
Latest funding round | Latest funding round $ 74m (almost 5 years ago) | Latest funding round N/A | Latest funding round $ 200m (about 5 years ago) | Latest funding round $ 3m (over 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 88m | Total funding raised N/A | Total funding raised $ 200m | Total funding raised $ 11.3m | Total funding raised $ 97.5m |
Eleison Pharmaceuticals is a company engaged in the discovery and commercialization of drug candidates for cancers.
View company
NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines.
View company
HDT Bio is a biopharmaceutical company intended to develop biotherapeutics for oncology and infectious disease applications.
View companyElevation Oncology is a biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers.
View company